Volume 140, Issue 2 , Pages 459-463, August 2010
CLOVES syndrome with thoracic and central phlebectasia: Increased risk of pulmonary embolism
Objective
CLOVES syndrome (congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and skeletal/scoliosis and spinal abnormalities) is a rare, complex overgrowth syndrome with serious morbidity. In this communication we studied the presence of central and thoracic phlebectasia in patients with CLOVES syndrome and its clinical implications.
Methods
We conducted a comprehensive search of our databases at Children's Hospital Boston over the last 10 years (1999–2008) for patients with CLOVES syndrome and central and thoracic phlebectasia. Medical records, clinical photographs, and imaging studies of varying modalities were reviewed.
Results
Review of the clinical data and imaging studies of 12 patients with CLOVES syndrome documented the presence of central and thoracic phlebectasia in 11 patients. Two patients had serious perioperative pulmonary embolism, and 1 died.
Conclusions
Central and thoracic phlebectasia in patients with CLOVES syndrome is common and increases the risk of pulmonary embolism. Aggressive prophylactic measures should be considered before major interventions.
Abbreviations and Acronyms: CLOVES, congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and skeletal/scoliosis and spinal abnormalities, CT, computed tomography, IVC, inferior vena cava, SVC, superior vena cava
To access this article, please choose from the options below
Disclosures: None.
PII: S0022-5223(10)00427-7
doi:10.1016/j.jtcvs.2010.04.023
© 2010 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Volume 140, Issue 2 , Pages 459-463, August 2010
